In-vitro Fertilization Services Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.
The global in-vitro fertilization services market is poised to accrue substantial gains, owing to regulations and initiatives launched by governments across the globe to ensure increased access to the IVF treatment.
For example, in October 2015, the Ministry of Health in Ontario announced an annual rise in funding by $50 million, to support the development of the IVF process. Likewise, in 2018, the Singapore government revealed a 75% co-funding for various assisted reproductive technologies (ART) procedures such as intracytoplasmic sperm injection, gamete intra-fallopian transfer, and in-vitro fertilization.
Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/3441
The global in-vitro fertilization services market is further projected to gain remarkable traction over the forecast spell, owing to the growing rates of male and female infertility, along with the prevalence of sexually transmitted diseases. Infertility is mainly caused by factors such as deficiency disorders and genetic defects.
As per Global Market Insights, Inc. estimates, the global in-vitro fertilization services market size is expected to surpass $17 billion by 2025.
In terms of segmentation by procedure, the in-vitro fertilization segment is set to depict a 7.8% growth rate through 2025. The segmental growth can be attributed to high success rate and low costs of this technique. Moreover, it caters to the adverse conditions such as blocked fallopian tubes, premature ovarian failure, and male infertility.
With regards to the age group spectrum, the global in-vitro fertilization services market from the 35-39 segment is expected to expand at a considerable growth rate, as the chances of conceiving among women of this age group are extremely low. Reliable reports suggest that women aged between 35-39 years have only a 20 percent chance of getting pregnant, thereby bolstering the in-vitro fertilization process demand.
Based on end-use, the fertility center segment registered revenue worth $4.6 billion in 2018 and is likely to accrue commendable profits in the coming years, owing to its high preference, favored by low infection rate and enhanced facilities being provided.
In addition, fertility centers are well equipped with technologically advanced IVF devices and are relatively more hygienic as compared to hospitals. These factors will increase the overall production value and drive the global in-vitro fertilization services market share over the estimated timeline.
With a key focus on achieving the best clinical outcomes in IVF treatment, key industry players are targeting to develop exceptional facility clinics. For instance, in July 2020, The Fertility Partners (TFP) announced the acquisition of The Reproductive Care Centre Mississauga, Heartland Fertility Winnipeg, Procrea Newmarket, Procrea Vaughan, Procrea Gatineau, Procrea Montreal, and Procrea Quebec City to establish the foundation of fertility clinics network in Canada. TFP is the partner of choice for various IVF and fertility clinicians in the region.
High prices associated with the IVF procedures and complications that may arise from this treatment will remain as key challenges for the global in-vitro fertilization services market expansion in years to come.
One in-vitro fertilization cycle costs nearly $12,000 to $15,000. Additionally, the costs of the medication can reach up to $3,000 per cycle. Low customer affordability, coupled with high complexity of the IVF process, is likely to hinder the global market dynamics in the foreseeable future.
On the regional front, the U.S. in-vitro fertilization services market is poised to depict a CAGR of 4.1% through 2025, driven by the accelerating infertility rate in the region.
As per authentic reports, nearly 6.1 million of the women aged between 15 to 44 years in the U.S. are affected by infertility problems, which will add impetus to the regional in-vitro fertilization services market size over the projected timeframe.
Likewise, the India in-vitro fertilization services market is expected to register $1.4 billion in revenue by 2025, which can be attributed to the increasing infertility prevalence and higher awareness regarding the benefits of IVF procedures. Studies suggest that nearly 10-14% of the Indian population is currently suffering from infertility.
Key in-vitro fertilization services industry players include Bourn Hall Fertility Clinic, AVA Clinic Scanfert, Bangkok IVF Center, Ovation Fertility, and IVIRMA Global. These firms are focusing on gaining lucrative growth opportunities via strategies such as M&A, business expansion, and new product launches.
To illustrate, in October 2019, Sverica Capital Management announced a strategic investment in In Vitro Sciences (IVS), which operates 17 offices including 4 IVF (in-vitro fertilization) labs. The transaction has enabled IVS to spin-out from Women’s Health USA and supported the acquisition of an Arizona-based fertility clinic, Advanced Fertility Care.
Browse full table of contents (TOC) of this report @ https://www.decresearch.com/toc/detail/in-vitro-fertilization-services-market
Partial Chapter of the Table of Content
Chapter 4. In-vitro Fertilization Services Market, By Product
4.1. Key segment trends
4.2. In-vitro fertilization (IVF)
4.2.1. Market size, by region, 2014 – 2025 (USD Million)
4.3. Intracytoplasmic sperm injection (ICSI)
4.3.1. Market size, by region, 2014 – 2025 (USD Million)
Chapter 5. In-vitro Fertilization Services Market, By Age Group
5.1. Key segment trends
5.2. Below 34
5.2.1. Market size, by region, 2014 – 2025 (USD Million)
5.3.1. Market size, by region, 2014 – 2025 (USD Million)
5.4.1. Market size, by region, 2014 – 2025 (USD Million)
5.5. 43 and Above
5.5.1. Market size, by region, 2014 – 2025 (USD Million)